SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia

Muscle Nerve. 2020 Aug;62(2):E48-E49. doi: 10.1002/mus.26988. Epub 2020 Jun 1.

Authors

Xiaowei W Su¹, Sydney V Palka¹, Rahul R Rao¹, Fred S Chen², Christopher R Brackney³, Franca Cambi¹

Affiliations

¹ Department of Neurology, Veterans Affairs Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
² Department of Physical Medicine and Rehabilitation, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
³ Department of Critical Care Medicine, Veterans Affairs Pittsburgh Healthcare System, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

No abstract available

Keywords: AIDP; COVID-19; Guillain-Barré syndrome; SARS-CoV-2; autonomic dysfunction.

Publication types

Case Reports
Letter

MeSH terms

Aged
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Diarrhea / etiology
Electromyography
Gram-Negative Bacterial Infections / diagnosis
Gram-Negative Bacterial Infections / etiology
Guillain-Barre Syndrome / diagnosis
Guillain-Barre Syndrome / etiology
Guillain-Barre Syndrome / physiopathology*
Guillain-Barre Syndrome / therapy
Humans
Hypertension / etiology
Hypertension / physiopathology
Hypotension / etiology
Hypotension / physiopathology
Immunoglobulins, Intravenous / therapeutic use
Immunologic Factors / therapeutic use
Inappropriate ADH Syndrome / etiology
Inappropriate ADH Syndrome / physiopathology*
Male
Neural Conduction*
Pandemics
Pneumonia, Ventilator-Associated / diagnosis
Pneumonia, Ventilator-Associated / etiology
Pneumonia, Viral / complications*
Primary Dysautonomias / diagnosis
Primary Dysautonomias / etiology
Primary Dysautonomias / physiopathology*
Primary Dysautonomias / therapy
Quadriplegia / etiology
Quadriplegia / physiopathology
SARS-CoV-2
Stenotrophomonas maltophilia
Tachycardia / etiology
Tachycardia / physiopathology

Substances

Immunoglobulins, Intravenous
Immunologic Factors